FDA Drug Recalls
17,898 recalls, newest first
Class I · High risk Ongoing Feb 14, 2023
Reason Chemical Contamination: FDA analysis found the product to contain methanol, acetaldehyde, and acetal above the limits.
Class I · High risk Terminated Feb 13, 2023
Reason Marketed Without An Approved NDA/ANDA: FDA analysis found the product to be tainted with undeclared sildenafil and tadalafil, ingredients found in…
Class II · Moderate risk Completed Feb 10, 2023
Reason Lack of sterility assurance: Recall of certain batches of 0.9% Sodium Chloride for Injection USP in EXCEL¿ Plus IV Container product due to the…
Class II · Moderate risk Completed Feb 10, 2023
Reason Lack of sterility assurance: Recall of certain batches of 0.9% Sodium Chloride for Injection USP in EXCEL¿ Plus IV Container product due to the…
Class II · Moderate risk Terminated Feb 9, 2023
Reason Failed Impurities/Degradation Specifications
Class II · Moderate risk Terminated Feb 9, 2023
Reason Failed Impurities/Degradation Specifications
Class II · Moderate risk Terminated Feb 9, 2023
Reason Failed Impurities/Degradation Specifications
Class II · Moderate risk Terminated Feb 9, 2023
Reason Failed Impurities/Degradation Specifications
Class II · Moderate risk Terminated Feb 9, 2023
Reason Failed Impurities/Degradation Specifications
Class II · Moderate risk Terminated Feb 9, 2023
Reason Failed Impurities/Degradation Specifications
Class II · Moderate risk Terminated Feb 9, 2023
Reason Failed Impurities/Degradation Specifications
Class II · Moderate risk Terminated Feb 9, 2023
Reason Failed Impurities/Degradation Specifications
Class II · Moderate risk Terminated Feb 9, 2023
Reason Failed Impurities/Degradation Specifications
Class II · Moderate risk Terminated Feb 9, 2023
Reason Failed Impurities/Degradation Specifications
Class II · Moderate risk Terminated Feb 9, 2023
Reason Failed Impurities/Degradation Specifications
Class II · Moderate risk Terminated Feb 9, 2023
Reason Failed Impurities/Degradation Specifications
Class II · Moderate risk Terminated Feb 9, 2023
Reason Failed Impurities/Degradation Specifications
Class II · Moderate risk Terminated Feb 9, 2023
Reason cGMP Deviation: Raw material recalled by repackager, due to discoloration of the epinephrine API.
Class II · Moderate risk Terminated Feb 9, 2023
Reason cGMP Deviation: Raw material recalled by repackager, due to discoloration of the epinephrine API.
Class II · Moderate risk Ongoing Feb 8, 2023
Reason Lack of assurance of sterility: Suspected microbial growth present on external label packaging.
Class II · Moderate risk Ongoing Feb 8, 2023
Reason Presence of Foreign Tablets/Capsules: Presence of one Tacrolimus 1 mg capsule co-mingled in a bottle containing and labeled as Tacrolimus 0.5 mg…
Class II · Moderate risk Terminated Feb 7, 2023
Reason CGMP Deviations: recalling drug products following an FDA inspection.
Class II · Moderate risk Terminated Feb 7, 2023
Reason CGMP Deviations: recalling drug products following an FDA inspection.
Class II · Moderate risk Terminated Feb 7, 2023
Reason CGMP Deviations: recalling drug products following an FDA inspection.
Class II · Moderate risk Terminated Feb 7, 2023
Reason CGMP Deviations: recalling drug products following an FDA inspection.